Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Prevention of cardiovascular disease by the early identification of erectile dysfunction

International Journal of Impotence Research volume 20, pages S9–S14 (2008)Cite this article

Abstract

Both erectile dysfunction (ED) and vascular disease share the same risk factors and the two conditions often coexist, with endothelial dysfunction being the common underlying pathophysiology. Up to two-thirds of all patients with clinically evident coronary artery disease (CAD) have ED. Because of their smaller size, the same degree of lipid plaque burden has a greater effect on the penile arteries compared with the coronary arteries. As a result, the clinical consequences of penile vascular disease (ED) frequently manifest 2–3 years before the consequences of coronary atherosclerosis. This phenomenon has led to the widespread view that ED is a silent marker of vascular disease, particularly CAD, in otherwise asymptomatic men. The Second Princeton Consensus Guidelines reflect this by stating that a man with ED and no cardiac symptoms should be considered a cardiac (or vascular) patient until proven otherwise. For most men with no cardiac symptoms, we therefore have 2–3 years from ED onset to reduce the risk of a cardiovascular event. This article discusses the rationale for the link between ED and CAD, with reference to endothelial dysfunction, and the role of ED as an important means of identifying men at risk of vascular disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    Article  CAS  Google Scholar 

  2. Ayta IA, McKinlay JB, Krane RJ . The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50–56.

    Article  CAS  Google Scholar 

  3. Jackson G . The importance of risk factor reduction in erectile dysfunction. Curr Urol Rep 2007; 8: 463–466.

    Article  Google Scholar 

  4. Solomon H, Man JW, Jackson G . Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251–254.

    Article  CAS  Google Scholar 

  5. Montorsi P, Montorsi F, Schulman CC . Is erectile dysfunction the ‘Tip of the Iceberg’ of a systemic vascular disorder. Eur Urol 2003; 44: 352–354.

    Article  Google Scholar 

  6. Jackson G . Erectile dysfunction: a marker of silent coronary artery disease. Eur Heart J 2006; 27: 2613–2614.

    Article  Google Scholar 

  7. Marx N, Grant PJ . Endothelial dysfunction and cardiovascular disease—the lull before the storm. Diab Vasc Dis Res 2007; 4: 82–83.

    Article  Google Scholar 

  8. De Angelis L, Marfella MA, Siniscalchi M, Marino L, Nappo F, Giugliano F et al. Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia 2001; 44: 1155–1160.

    Article  CAS  Google Scholar 

  9. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A et al. Common grounds for erectile dysfunction and coronary heart disease. Curr Opin Urol 2004; 14: 361–365.

    Article  Google Scholar 

  10. Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003; 44: 360–365.

    Article  Google Scholar 

  11. Kloner RA, Mullin SH, Shook T, Matthews R, Mayeda G, Burstein S et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol 2003; 170: S46–S50.

    Article  Google Scholar 

  12. Solomon H, Man JW, Wierzbicki AS, Jackson G . Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol 2003; 91: 230–231.

    Article  Google Scholar 

  13. Hodges LD, Kirby M, Solanki J, O’Donnell J, Brodie DA . The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract 2007; 61: 2019–2025.

    Article  CAS  Google Scholar 

  14. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004; 110: 22–26.

    Article  Google Scholar 

  15. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA . Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005; 294: 2996–3002.

    Article  CAS  Google Scholar 

  16. Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S . Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 2005; 48: 512–518.

    Article  Google Scholar 

  17. Schouten BW, Bohnen AM, Bosch JL, Bernsen RM, Deckers JW, Dohle GR et al. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen study. Int J Impot Res 2008; 20: 92–99.

    Article  CAS  Google Scholar 

  18. Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z . Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123–126.

    Article  CAS  Google Scholar 

  19. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Veglia F, Briganti A et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006; 27: 2632–2639.

    Article  Google Scholar 

  20. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M et al. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. J Hypertens 2001; 19: 1139–1147.

    Article  CAS  Google Scholar 

  21. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre, randomised, placebo-controlled trial. Lancet 2004; 364: 685–696.

    Article  CAS  Google Scholar 

  22. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149–1158.

    Article  CAS  Google Scholar 

  23. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ et al. Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia 2005; 48: 2482–2485.

    Article  CAS  Google Scholar 

  24. Jackson G, Padley S . Erectile dysfunction and silent coronary artery disease: abnormal CT coronary angiogram in the presence of normal exercise ECGs. Int J Clin Pract 2008; 62: 973–976.

    Article  CAS  Google Scholar 

  25. Jackson G, Rosen RC, Kloner RA, Kostis JB . The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 2006; 3: 28–36.

    Article  CAS  Google Scholar 

  26. Jackson G . Erectile dysfunction and vascular risk: let's get it right. Eur Urol 2006; 50: 660–661.

    Article  Google Scholar 

  27. Poulter N . Coronary heart disease is a multifactorial disease. Am J Hypertens 1999; 12: 92S–95S.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author would like to acknowledge medical writing support by Julie Adkins (a Senior Medical Writer contracted to GCC) and Jackie Phillipson of Gardiner-Caldwell Communications; this support was funded by Eli Lilly and Company. Diane Stothard (Eli Lilly and Company) provided support by reviewing this article.

Author information

Authors and Affiliations

  1. Cardiothoracic Centre, Guy's and St Thomas’ NHS Foundation Trust, London, UK

    G Jackson

Authors
  1. G Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Jackson.

Additional information

Disclosure

Graham Jackson has received lecture fees from Pfizer and Eli Lilly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jackson, G. Prevention of cardiovascular disease by the early identification of erectile dysfunction. Int J Impot Res 20 (Suppl 2), S9–S14 (2008). https://doi.org/10.1038/ijir.2008.47

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2008.47

This article is cited by

Search

Advanced search

Quick links